⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetonitrile SCHEMBL2675205 | 1.00 | ALDH1A1 (0.61) | — | |
| Acetonitrile SCHEMBL19552198 | 1.00 | ALDH1A1 (0.61) | — | |
| Acetonitrile SCHEMBL28358952 | 0.93 | ALDH1A1 (0.53) | — | |
| Acetonitrile SCHEMBL28397723 | 0.93 | ALDH1A1 (0.53) | — | |
| Water SCHEMBL27670184 | 0.83 | ALDH1A1 (0.89) | — | |
| Water SCHEMBL2652847 | 0.83 | — | — | |
| Water SCHEMBL10335432 | 0.83 | — | — | |
| Hexane SCHEMBL2675802 | 0.83 | ALDH1A1 (0.42) | — | |
| Hexane SCHEMBL8597024 | 0.83 | ALDH1A1 (0.42) | — | |
| Ammonia Solution, Strong SCHEMBL26699157 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4399207-A1 | CRYSTALLINE FORMS OF QUINAZOLINE DERIVATIVES, PREPARATION, COMPOSITION AND USE THEREOF | F. Hoffmann-La Roche AG (CH) | 2024-07-17 | — | — | EP | claimed |
| CN-114258394-B | Crystal form of oncogenic fusion kinase inhibitor and application thereof | 南京再明医药有限公司 | 2024-04-23 | — | — | CN | claimed |
| US-20240043430-A1 | CRYSTAL FORM OF CASEIN KINASE 1e INHIBITOR AND PREPARATION METHOD AND USE THEREOF | Hangzhou Healzen Therapeutics Co., Ltd. (CN) | 2024-02-08 | — | — | US | claimed |
| EP-4269412-A1 | CRYSTAL FORM OF CASEIN KINASE 1E INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Hangzhou Healzen Therapeutics Co., Ltd. (CN) | 2023-11-01 | — | — | EP | claimed |
| CN-114428133-B | Method for detecting content of impurity XV in tacrolimus ointment by using reversed phase chromatography | 江苏知原药业股份有限公司 | 2023-06-09 | — | — | CN | claimed |
| WO-2023066296-A1 | CRYSTALLINE FORMS OF QUINAZOLINE DERIVATIVES, PREPARATION, COMPOSITION AND USE THEREOF | SUZHOU ZANRONG PHARMA LIMITED (CN) | 2023-04-27 | — | — | WO | claimed |
| EP-3508478-B1 | SALT DERIVATIVE OF TETRAHYDROISOQUINOLINE AND CRYSTALLINE THEREOF AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | CHINA STATE INST PHARM IND (CN) | 2022-12-21 | — | — | EP | claimed |
| EP-4023648-A1 | CRYSTAL OF CARCINOGENIC FUSED KINASE INHIBITOR AND APPLICATIONS THEREOF | Simcere Pharmaceutical Co. Ltd. (CN) | 2022-07-06 | — | — | EP | claimed |
| CN-114656468-A | Crystal form of casein kinase 1 epsilon inhibitor, preparation method and application thereof | 杭州和正医药有限公司 | 2022-06-24 | — | — | CN | claimed |
| CN-114428133-A | Method for detecting impurity XV content in tacrolimus ointment by using reverse phase chromatography | 江苏知原药业股份有限公司 | 2022-05-03 | — | — | CN | claimed |
| EP-3508478-A1 | SALT DERIVATIVE OF TETRAHYDROISOQUINOLINE AND CRYSTALLINE THEREOF AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | China State Institute of Pharmaceutical Industry (CN) | 2019-07-10 | — | — | EP | claimed |
| US-20190177277-A1 | SALT DERIVATIVE OF TETRAHYDROISOQUINOLINE AND CRYSTALLINE THEREOF AND PREPARATION METHOD THEREFORE AND APPLICATION THEREOF | SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) | 2019-06-13 | — | — | US | claimed |
| EP-2279220-B1 | A METHOD FOR PREPARING HIGH-PURITY POLYETHYLENEGLYCOL ALDEHYDE DERIVATIVES | ID BIOCHEM INC (KR) | 2014-07-02 | — | — | EP | claimed |
| CN-102037056-B | Process for preparing high purity polyethylene glycol aldehyde derivatives | ID BIOCHEM INC | 2013-04-10 | — | — | CN | claimed |
| US-8349969-B2 | Method for preparing high-purity polyethyleneglycol aldehyde derivatives | ID BIOCHEM, INC. (KR) | 2013-01-08 | — | — | US | claimed |
| CN-102037056-A | Process for preparing high purity polyethylene glycol aldehyde derivatives | ID BIOCHEM INC | 2011-04-27 | — | — | CN | claimed |
| US-20110071262-A1 | METHOD FOR PREPARING HIGH-PURITY POLYETHYLENEGLYCOL ALDEHYDE DERIVATIVES | ID BIOCHEM, INC. (KR) | 2011-03-24 | — | — | US | claimed |
| EP-2279220-A2 | A METHOD FOR PREPARING HIGH-PURITY POLYETHYLENEGLYCOL ALDEHYDE DERIVATIVES | ID Biochem, Inc. (KR) | 2011-02-02 | — | — | EP | claimed |
| WO-2009142423-A2 | A METHOD FOR PREPARING HIGH-PURITY POLYETHYLENEGLYCOL ALDEHYDE DERIVATIVES | ID BIOCHEM, INC. (KR) | 2009-11-26 | — | — | WO | claimed |
| WO-1996022300-A1 | THERMODYNAMICALLY STABLE CRYSTAL FORM OF 4'-DEOXY-4'-EPI-METHYLAMINO AVERMECTIN B1a/B1b BENZOIC ACID SALT AND PROCESSES FOR ITS PREPARATION | MERCK & CO., INC. (US) | 1996-07-25 | — | — | WO | claimed |